BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21262441)

  • 1. APS--controversies in diagnosis and management, critical overview of current guidelines.
    Pengo V
    Thromb Res; 2011 Feb; 127 Suppl 3():S51-2. PubMed ID: 21262441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies--we are not quite there yet.
    Urbanus RT; de Groot PG
    Blood Rev; 2011 Mar; 25(2):97-106. PubMed ID: 21242018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation and recommended testing for antiphospholipid antibodies.
    Galli M
    Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLC immunostaining for detection of "antiphospholipid" antibodies.
    Conti F; Alessandri C; Spinelli FR; Capozzi A; Martinelli F; Recalchi S; Misasi R; Valesini G; Sorice M
    Methods Mol Biol; 2014; 1134():95-101. PubMed ID: 24497357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does seronegative antiphospholipid syndrome really exist?
    Cervera R; Conti F; Doria A; Iaccarino L; Valesini G
    Autoimmun Rev; 2012 Jun; 11(8):581-4. PubMed ID: 22036830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
    Pierangeli SS; de Groot PG; Dlott J; Favaloro E; Harris EN; Lakos G; Ortel T; Meroni PL; Otomo K; Pengo V; Tincani A; Wong R; Roubey R
    Lupus; 2011 Feb; 20(2):182-90. PubMed ID: 21303835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-beta2-glycoprotein I antibodies--when and how should they be measured?
    Reber G; de Moerloose P
    Thromb Res; 2004; 114(5-6):527-31. PubMed ID: 15507287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprothrombin antibody testing: detection and clinical utility.
    Oku K; Atsumi T; Amengual O; Koike T
    Semin Thromb Hemost; 2008 Jun; 34(4):335-9. PubMed ID: 18814066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
    Ruffatti A; Tonello M; Del Ross T; Cavazzana A; Grava C; Noventa F; Tona F; Iliceto S; Pengo V
    Thromb Haemost; 2006 Sep; 96(3):337-41. PubMed ID: 16953276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.